Investors Grab RVNC Even Cheaper Than Its Secondary Stock Offering
February 05, 2018 at 15:43 PM EST
Looking back to 60 days ago, Revance Therapeutics Inc (RVNC) priced a 5,338,709 share secondary stock offering at $31.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..